# The Medicines for Human Use (Clinical Trials) Amendment Regulations 2006, Regulation 21: Amendment of regulation 41 of the principal Regulations


In regulation 41 of the principal Regulations (application and effect of manufacturing authorisation)—
(a) in paragraph (b), omit “and”; and
(b) after paragraph (b), insert the following paragraph—
“(bb) in the case of an authorisation relating to the inactivation of viral or non-conventional agents, the manufacturing process; and”.

---
Source: https://www.legislation.gov.uk/uksi/2006/1928/regulation/21 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-amendment-regulations-2006/regulation-21
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.